Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/222332
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Repurposing zileuton as a depression drug using an AI and in vitro approach |
Autor: | Kubick, Norwin; Pajares, Marta CSIC; Enache, Ioana; Manda, Gina; Mickael, Michel-Edwar | Palabras clave: | Depression Macrophages NRF2 Text mining Deep neural network AI |
Fecha de publicación: | 2020 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Molecules 25(9): 2155 (2020) | Resumen: | Repurposing drugs to target M1 macrophages inflammatory response in depression constitutes a bright alternative for commonly used antidepressants. Depression is a significant type of mood disorder, where patients suffer from pathological disturbances associated with a proinflammatory M1 macrophage phenotype. Presently, the most commonly used antidepressants such as Zoloft and Citalopram can reduce inflammation, but suffer from dangerous side effects without offering specificity toward macrophages. We employed a new strategy for drug repurposing based on the integration of RNA-seq analysis and text mining using deep neural networks. Our system employs a Google semantic AI universal encoder to compute sentences embedding. Sentences similarity is calculated using a sorting function to identify drug compounds. Then sentence relevance is computed using a custom-built convolution differential network. Our system highlighted the NRF2 pathway as a critical drug target to reprogram M1 macrophage response toward an anti-inflammatory profile (M2). Using our approach, we were also able to predict that lipoxygenase inhibitor drug zileuton could modulate NRF2 pathway in vitro. Taken together, our results indicate that reorienting zileuton usage to modulate M1 macrophages could be a novel and safer therapeutic option for treating depression. | Descripción: | This article belongs to the Special Issue AI in Drug Design. | Versión del editor: | https://doi.org/10.3390/molecules25092155 | URI: | http://hdl.handle.net/10261/222332 | DOI: | 10.3390/molecules25092155 | E-ISSN: | 1420-3049 |
Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
repurappro.pdf | 3,2 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
6
checked on 27-mar-2024
SCOPUSTM
Citations
9
checked on 28-mar-2024
WEB OF SCIENCETM
Citations
8
checked on 28-feb-2024
Page view(s)
129
checked on 29-mar-2024
Download(s)
231
checked on 29-mar-2024